Papers

Research literature with structured metadata.

Trials

Registered studies by status, phase, and compound.

Topics

Indications and themes psychedelics are researched for.

Compounds

Evidence across molecules with rich data.

Countries

Regulation, access, and research activity by region.

Stakeholders

Organizations shaping the space across research, policy, and funding.

People

Investigators, clinicians, and authors with mapped output.

Courses

Training programs and certifications across modalities.

Events

Conferences, workshops, and convenings by date and focus.

Research recaps

Monthly evidence summaries with key takeaways.

Map of research

Landscape view of trials, compounds, and outcomes.

Newsletter

Weekly or daily updates on trials, publications, analysis, and more.

Research Groups

Worldwide map of psychedelic research centres by region.

Research Network

Interactive co-authorship map of psychedelic researchers.

Top papers

Find needles in the haystack of psychedelic research per topic.

Pricing
Back to Stakeholders
HospitalsIndependent Academic Research Groups

Brigham and Women's Hospital

United States
5 Trials

Major academic medical center in Boston affiliated with Harvard Medical School and part of the Mass General Brigham health system. Researchers at BWH are active in the emerging field of psychedelic-assisted therapy, including psilocybin studies for gastrointestinal conditions and ethical frameworks for psychedelic pain research.

Quick Facts

Type
Other
HQ
United States
Website
Visit

Sponsored Trials

5
Not yet recruitingII

Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder

Start Date
May 1, 2026
Compounds
Psilocybin
TerminatedII

Ketamine for OUD and Suicidal Ideation in the ED

Start Date
March 1, 2024
Compounds
Ketamine, Placebo
WithdrawnII

Ketamine for the Treatment for Alcohol Use Disorder in the ED

Start Date
October 25, 2023
Compounds
Ketamine, Placebo
Enrolling by invitationIV

Comparative Effectiveness of ECT vs. KETAMINE Over the Lifespan (REaKT-SD)

Start Date
October 1, 2023
Compounds
Ketamine, Placebo
TerminatedII

MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer

Start Date
January 12, 2007
Compounds
MDMA

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.